168 related articles for article (PubMed ID: 24764358)
1. Trimeric knob protein specifically distinguishes neutralizing antibodies to different human adenovirus species: potential application for adenovirus seroepidemiology.
Yu B; Dong J; Wang C; Wang Z; Gao L; Zhang H; Wu J; Kong W; Yu X
J Gen Virol; 2014 Jul; 95(Pt 7):1564-1573. PubMed ID: 24764358
[TBL] [Abstract][Full Text] [Related]
2. Identification of adenovirus neutralizing antigens using capsid chimeric viruses.
Liu T; Fan Y; Li X; Gu S; Zhou Z; Xu D; Qiu S; Li C; Zhou R; Tian X
Virus Res; 2018 Sep; 256():100-106. PubMed ID: 30096411
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera.
Yu B; Dong J; Wang C; Zhan Y; Zhang H; Wu J; Kong W; Yu X
Virology; 2013 Mar; 437(2):118-23. PubMed ID: 23351390
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection.
Bradley RR; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
J Virol; 2012 Jan; 86(1):625-9. PubMed ID: 22072776
[TBL] [Abstract][Full Text] [Related]
5. Broadly neutralizing monoclonal antibodies against human adenovirus types 55, 14p, 7, and 11 generated with recombinant type 11 fiber knob.
Tian X; Fan Y; Liu Z; Zhang L; Liao J; Zhou Z; Li X; Liu T; Liu W; Qiu H; Zhou R
Emerg Microbes Infect; 2018 Dec; 7(1):206. PubMed ID: 30531794
[TBL] [Abstract][Full Text] [Related]
6. Rapid identification of subgenera of human adenovirus by serological and PCR assays.
Akalu A; Seidel W; Liebermann H; Bauer U; Döhner L
J Virol Methods; 1998 Apr; 71(2):187-96. PubMed ID: 9626952
[TBL] [Abstract][Full Text] [Related]
7. Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector.
Liu M; Tian X; Li X; Zhou Z; Li C; Zhou R
PLoS One; 2014; 9(7):e103058. PubMed ID: 25054273
[TBL] [Abstract][Full Text] [Related]
8. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions.
Qiu H; Li X; Tian X; Zhou Z; Xing K; Li H; Tang N; Liu W; Bai P; Zhou R
J Virol; 2012 Aug; 86(15):7964-75. PubMed ID: 22623776
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.
Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098
[TBL] [Abstract][Full Text] [Related]
10. Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector.
Myhre S; Henning P; Granio O; Tylö AS; Nygren PA; Olofsson S; Boulanger P; Lindholm L; Hong SS
Gene Ther; 2007 Feb; 14(4):376-81. PubMed ID: 17036056
[TBL] [Abstract][Full Text] [Related]
11. Detection of antibodies against adenovirus protein IX, fiber, and hexon in human sera by immunoblot assay.
Bauer U; Flunker G; Bruss K; Kallwellis K; Liebermann H; Luettich T; Motz M; Seidel W
J Clin Microbiol; 2005 Sep; 43(9):4426-33. PubMed ID: 16145087
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions.
Bradley RR; Maxfield LF; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
J Virol; 2012 Jan; 86(2):1267-72. PubMed ID: 22072746
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
Sumida SM; Truitt DM; Lemckert AA; Vogels R; Custers JH; Addo MM; Lockman S; Peter T; Peyerl FW; Kishko MG; Jackson SS; Gorgone DA; Lifton MA; Essex M; Walker BD; Goudsmit J; Havenga MJ; Barouch DH
J Immunol; 2005 Jun; 174(11):7179-85. PubMed ID: 15905562
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping and characterization of a neutralizing monoclonal antibody against human adenovirus type 3.
Tian X; Li C; Xue C; Li X; Zhou Z; Zhou R
Virus Res; 2013 Nov; 177(2):189-93. PubMed ID: 24018287
[TBL] [Abstract][Full Text] [Related]
15. Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity.
Feng Y; Sun X; Ye X; Feng Y; Wang J; Zheng X; Liu X; Yi C; Hao M; Wang Q; Li F; Xu W; Li L; Li C; Zhou R; Chen L; Feng L
Virology; 2018 May; 518():272-283. PubMed ID: 29550678
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping and cross-reactivity analysis of the monoclonal antibodies against hexon protein of human adenovirus type 3.
Qiu H; Zhou Z; Feng K; Tian X; Li X; Li H; Xing K; Chen J; Li C; Zhou R
Virus Res; 2009 Dec; 146(1-2):58-65. PubMed ID: 19732803
[TBL] [Abstract][Full Text] [Related]
17. Development of two antigen-binding fragments to a conserved linear epitope of human adenovirus and their application in immunofluorescence.
Liu Z; Tian X; Liu W; Xian Y; Chen W; Chen H; Zhou R
PLoS One; 2019; 14(6):e0219091. PubMed ID: 31242267
[TBL] [Abstract][Full Text] [Related]
18. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.
Gahéry-Ségard H; Farace F; Godfrin D; Gaston J; Lengagne R; Tursz T; Boulanger P; Guillet JG
J Virol; 1998 Mar; 72(3):2388-97. PubMed ID: 9499099
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon.
Tian X; Su X; Li H; Li X; Zhou Z; Liu W; Zhou R
Virus Res; 2011 Sep; 160(1-2):214-20. PubMed ID: 21740937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
